Altamira Therapeutics Ltd.: net_income
| Value | {"unit": "CHF", "value": -11496401, "concept": "us-gaap:NetIncomeLoss"} |
|---|---|
| Period | 2018-01-01 – 2018-12-31 |
| Status | current |
| Entity | Altamira Therapeutics Ltd. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T16:24:25.793555+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/035888a9-7e08-41ca-b35d-7a8dc33b0047
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-21-018959Retrieved: 2026-08-19T16:24:25.793555+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001601936/net-income/2018-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/035888a9-7e08-41ca-b35d-7a8dc33b0047
History
- no predecessors — first report